Mitsubishi Tanabe Obtains Remicade Additional Indication Of Ulcer Colitis
This article was originally published in PharmAsia News
Executive SummaryMitsubishi Tanabe Obtains Remicade Additional Indication Of Ulcer Colitis
You may also be interested in...
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.